Tag: Cancer: Bladder
Patient Experience Linked to Urologic CA Surgical Outcomes
Less prolonged hospitalization, fewer nursing-sensitive complications in high-performing hospitals
ASCO: Immunotherapy Beneficial in Advanced Bladder Cancer
About a quarter of older patients deemed too frail for chemo responded to atezolizumab
FDA Approves Tecentriq to Treat Urothelial Carcinoma
FDA also approves a companion test to detect PD-L1 protein expression levels in patients
Well Water a Suspected Cause of Bladder Cancer in New England
Researchers believe arsenic exposure might contribute to higher-than-normal rates
Optimally Timed Follow-Up Cuts Readmissions After Cystectomy
Timing, frequency of outpatient care helps identify concerning symptoms following radical cystectomy
Pioglitazone Linked to Increased Risk of Bladder Cancer
Duration- and dose-response associations for pioglitazone; no correlation for rosiglitazone
ASCO Endorses European Guideline on Bladder Cancer
Guideline on muscle-invasive and metastatic bladder cancer, with qualifying statements
Evidence Links Agent Orange to Bladder Cancer, Hypothyroidism
Also, veterans with Parkinson's-like symptoms can file claim for the condition
Cystectomy Plus Chemo Ups Survival in Bladder Cancer
Improved survival with adjuvant chemotherapy in patients with locally advanced disease
ASCO Genitourinary Cancers Symposium, Jan. 7-9
The ASCO 2016 Genitourinary Cancers Symposium The annual Genitourinary Cancers Symposium of the American Society of Clinical Oncology was held from Jan. 7...
